- Israel hits symbols of Hamas rule; scores killed
- Mississippi abortion law can’t be enforced
- Teacher who survived Sandy Hook has book deal
- Jury awards Jesse Ventura $1.8M in case vs. ‘American Sniper’ author Chris Kyle
- Middle Eastern firm’s deal to manage U.S. cargo port raises security concerns
- Bob McDonnell’s defense: Lonely wife developed ‘crush’ on CEO
- Chinese hackers stole ‘huge quantities’ of sensitive data on Israel’s Iron Dome
- House Republicans unveil bill to speed deportations of border children
- Californians protest middle school for hiring white man to teach cultural studies
- Killer’s sentencing overturned because mother couldn’t find seat in courtroom
Journal editors question sale of diet pill Meridia
Question of the Day
The drug, also known as sibutramine, is sold under a variety of names around the world.
An FDA advisory panel will review the study at a Sept. 15 meeting, while the next day it will consider approval of a new weight-loss drug, lorcaserin. Drugmakers have struggled to come up with a pill that doesn’t have risky side effects. The panel voted against another experimental diet drug in July because of its side effects.
TWT Video Picks
- Tactical advantage: Russian military shows off impressive new gear
- Obama thanks Muslims for 'building the very fabric of our nation'
- Federal judge grants 90-day stay in D.C. gun case
- McCLAUGHRY: Finish off the "Islamic State" quickly and cheaply
- Obama's brother wears Hamas scarf bearing anti-Israel slogans in photo
- Boehner rules out impeachment: 'Scam started by Democrats'
- Obama: 'Not a new Cold War,' but new Russia sanctions announced
- D.C. seeks to stay judge's order allowing gun owners to carry in public
- HUSAIN: Fleeing Iraqi Christians find safe haven at the Shrine of Imam Ali
- White House says Russia 'losing' war in Ukraine
Obama's biggest White House 'fails'
Celebrities turned politicians
Athletes turned actors
20 gadgets that changed the world